Kit Rapid Test Sofia® Fluorescence Immunoassay SARS Antigen FIA Nasal Swab / Nasopharyngeal Swab 25 Tests (25 TESTS/KT) (12 KT/CS) by Quidel Corporation ID 20374

188-1-2284
      
Stock Est. Shipping Date: 23rd May 2025

Kit Rapid Test Sofia® Fluorescence Immunoassay SARS Antigen FIA Nasal Swab / Nasopharyngeal Swab 25 Tests (25 TESTS/KT) (12 KT/CS)
Sold by: KT OF 25

 Reviews
Better together

  • Total: $0.00

Rally #188-1-2284
Quidel #20374
Sofia® SARS Antigen FIA (25 Test/KT 12 KT/CS)

Respiratory Test Kit, SARS-CoV-2, Lateral Flow Immunofluorescent Sandwich Assay, Anterior Nasal Swab, Rx Only, CLIA Complexity Waived

Features
  • Accurate detection with direct samples
  • Rapid results in 15 minutes
  • All necessary components included in kit are ready for use with Sofia 2 and Sofia for nasal swab procedure
  • Room temperature storage
The Sofia SARS Antigen FIA is a lateral flow immunofluorescent sandwich assay that is used with the Sofia, Sofia 2, and Sofia Q instrument intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in direct anterior nasal (NS) swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first five (5) days of symptom onset when tested at least twice over three days with at least 48 hours between tests, or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested at least three times over five days with at least 48 hours between tests.

This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

The Sofia SARS Antigen FIA does not differentiate between SARS-CoV and SARS-CoV-2.

All negative results are presumptive and confirmation with a molecular assay, if necessary for patient management, may be performed. Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions.

The Sofia SARS Antigen FIA is intended for use by medical professionals or operators who are proficient in performing tests in a point of care setting.

Important Note:
  • Product is non-returnable; please make sure it is the right product before ordering.
  • If put into refrigeration, do not freeze.
  • For in vitro diagnostic use.
  • Rx Only.
  • For use under an Emergency Use Authorization (EUA) only.
  • For more information on this product's EUA, please go to the EUA section below.
For the State of California:
Warning: This product can expose you to chemicals known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.

×
Rally #188-1-2284
Manufacturer #20374
BrandSofia®
ManufacturerQuidel
Country of OriginUnited States
ApplicationRespiratory Test Kit
CLIA ComplexityCLIA Waived
For Use WithFor use with Sofia / Sofia 2 Instrument
Number of Tests25 Tests
Reading TypeMachine Read
Sample TypeDirect Nasal Swabs
SpecialtyImmunoassay
TechnologyLateral Flow Immunofluorescent Sandwich Assay
Test FormatCassette Format
Test Kit TypeRapid
Test NameSARS Antigen FIA
Test TypeFluorescence Immunoassay (FIA)
Time to Results15 Minute Results
UNSPSC Code41116205
Kit Storage ConditionsRoom Temperature (15°C to 35°C / 59°F to 86°F)
ControlsPositive and Negative, Included In Kit
PPA96.7%
NPA100%


×
Currently Unavailable

×
Reagents and Materials Supplied - 20374 (25-Test Kit)
  • Individually Packaged Test Cassettes (25): Monoclonal anti-SARS antibodies
  • Reagent Tubes (25): Lyophilized buffer with detergents and reducing agents
  • Reagent Solution (25): Ampoules with salt solution
  • Sterile Nasal Swabs (Kits #20374) (25)
  • Small, Clear 120 µL Fixed Volume Pipettes (25)
  • SARS Positive Control Swab (1): Swab is coated with non-infectious recombinant SARS antigens
  • Negative Control Swab (1): Swab is coated with heat-inactivated, non-infectious Streptococcus C antigen
  • Package Insert (1)
  • Quick Reference Instructions (1)
  • QC Card (located on kit box)
×
Promotions are currently not available at this time. Please check back later.

×

- Reimbursements Information -

This product maybe reimbursable, depending on various factors including current law and policies. Rally Inc. does not handle these reimbursements; instead, each reimbursement is handled solely between you, the customer, and the manufacturer, QuidelOrtho. Rally Inc. does not oversee these reimbursements. To check eligibility and get your reimbursements, please follow the manufacturer's reimbursements instructions.

You can find more informations on reimbursement details here.

×

EUA - Emergency Use Authorization

In the USA, this product has not been FDA cleared or approved, but has been authorized by FDA under an Emergency Use Authorization (EUA) for use by authorized laboratories; use by laboratories certified under the CLIA that meet the requirements to perform moderate, high or waived complexity tests. This product is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens.

The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. §360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.


No recommended products at the moment.